Semaglutide vs Tirzepatide
Both are injectable GLP-1 medications for weight loss, but they work differently. Here's what matters for your decision.
See Which One You Qualify ForAt a Glance
Key differences between these two treatments
Semaglutide
Advantages
- Most clinical data available
- Proven cardiovascular benefits
- Lower monthly cost
- Well-established safety profile
Considerations
- •Single-receptor mechanism
- •Slightly lower average weight loss vs tirzepatide
Tirzepatide
Advantages
- Highest average weight loss in trials
- Dual-receptor mechanism
- Strong blood sugar control
- May improve insulin sensitivity more
Considerations
- •Higher monthly cost
- •Newer medication with less long-term data
Feature Comparison
A detailed look at how these medications stack up
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Monthly Price | $299/mo | $399/mo |
| How It Works | GLP-1 agonist | GLP-1 + GIP dual agonist |
| How You Take It | Weekly injection | Weekly injection |
| Avg. Weight Loss | 15-20% | 20-25% |
| When Results Start | 4-8 weeks | 4-8 weeks |
| Virtual Consultations | ||
| Free Shipping | ||
| Cancel Anytime |
The Bottom Line
Both are excellent options. Semaglutide is the most-studied GLP-1 with proven heart benefits and a lower price point — a great first choice for most people. Tirzepatide's dual mechanism produces slightly higher average weight loss and may be worth the extra cost if maximum results are your priority. Your TMates physician will help you choose based on your health profile, goals, and budget.
Who Should Choose Semaglutide?
Semaglutide may be the better fit if you:
- Want the most extensively studied GLP-1 medication
- Have cardiovascular risk factors (proven heart benefits in clinical trials)
- Prefer the lower price point while still getting strong results
- Are starting GLP-1 therapy for the first time
In the STEP clinical trials, semaglutide patients lost an average of 15-20% of their body weight over 68 weeks. That's roughly 35-45 pounds for someone starting at 220 lbs.
Who Should Choose Tirzepatide?
Tirzepatide may be the better fit if you:
- Want the highest possible weight loss from medication
- Have type 2 diabetes or significant insulin resistance
- Have tried semaglutide and want to explore an alternative
- Are less price-sensitive and prioritize maximum results
In the SURMOUNT-1 trial, tirzepatide patients on the highest dose lost an average of 22.5% of their body weight — roughly 50+ pounds for someone starting at 230 lbs.
How the Mechanisms Differ
Semaglutide activates the GLP-1 receptor, which suppresses appetite, slows gastric emptying, and improves insulin secretion.
Tirzepatide activates both GLP-1 and GIP receptors. The addition of GIP (glucose-dependent insulinotropic polypeptide) provides an additional pathway for appetite regulation and may enhance fat metabolism.
Think of it this way: semaglutide pulls one lever very effectively, while tirzepatide pulls two levers at once.
Side Effects Are Similar
Both medications share similar side effect profiles, primarily gastrointestinal:
- Nausea — most common, usually improves within 2-4 weeks
- Decreased appetite — this is actually part of how they work
- Mild GI discomfort — constipation or diarrhea in some patients
Your TMates physician starts you on a low dose and gradually increases it, which significantly reduces side effects for most patients.
The Bottom Line
You can't go wrong with either medication. The best choice depends on your health history, goals, and budget. The good news? You don't have to decide alone — our physicians will review your full health profile and recommend the option that gives you the best chance of success.
Not sure which is right for you?
Our physicians will review your health profile and recommend the best medication for your goals.
Start Your Free Assessment